Abstract:Background: Glioblastoma multiforme (GBM) is the most common and malignant primary brain tumor, GBM's inevitable recurrence suggests that glioblastoma stem cells (GSC) render these tumors persistent. Our previous work showed that FOSL1, which is transactivated by the STAT3 gene, functions as a tumorigenic gene in glioma pathogenesis and is a diagnostic marker and potential drug target for glioma patients. Accumulating evidence shows that STAT3 and NF-κB cooperate to promote the development and progression of various cancers. The link between STAT3 and NF-κB suggests that NF-κB can also transcriptionally regulate FOSL1 and contribute to gliomagenesis. Methods: 1). To investigate downstream molecules of FOSL1, we analyzed the transcriptome after overexpression of FOSL1 in a PDX-L14 line, characterized by very low FOSL1 expression 2). We conducted immunohistochemical staining for FOSL1 and p65 using rabbit polyclonal anti-FOSL1 and p65 in glioma tissue microarrays (TMA) derived from 76 glioma patients and 10 normal individuals. 3). Mutants of the human FOSL1 promoter, featuring mutations in essential binding sites for NF-κB and STAT3, were generated using a Q5 site-directed mutagenesis kit. Subsequently, we examined luciferase activity in glioma cells and compared it to the wild-type FOSL1 promoter. 4). We explore the mutual regulation between NF-κB signaling and FOSL1 by modulating the expression of NF-κB or FOSL1. Subsequently, we assessed the activity of FOSL1 and NF-κB. 5) To understand the role of FOSL1 in cell growth and stemness, we conducted a CCK-8 assay, cell cycle analysis, assessing apoptosis and GSC markers, ALDH1 and CD133 under varying FOSL1 expression conditions. Results: 1) Transcriptome analyses of downstream molecules of FOSL1 show that NF-κB signaling pathways are regulated by FOSL1. 2) p65 protein expression correlates to the expression of FOSL1 in glioma patients. 3) NF-κB is a crucial transcription factor activating the FOSL1 promoter in glioma cells. 4) Mutual regulation between NF-κB and FOSL1 contributes to glioma tumorigenesis and stemness through promoting G1/S transition and inhibition of apoptosis. Conclusion: The FOSL1 molecular pathway is functionally connected to NF-κB and STAT3 activation, enhances stemness, and FOSL1 is a novel GBM drug target. Citation Format: Mingli Liu, Vanajothi Ramar, Azam Khedri, BreAnna Hudson, Shanchun Guo. FOSL1 promotes glioma tumorigenesis and stemness through NF-κB and STAT3 pathways [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 5388.

A novel promoter-associated non-coding small RNA paGLI1 recruits FUS/ P65 to transactivate GLI1 gene expression and promotes infiltrating glioma progression

Long Non‑coding RNA LINC00473/miR‑195‑5p Promotes Glioma Progression Via YAP1‑TEAD1‑Hippo Signaling.

Glioma-associated Oncogene Homolog 1 Stimulates FOXP3 to Promote Non-Small Cell Lung Cancer Stemness.

A Novel Lncrna‐linc01116 Regulates Tumorigenesis of Glioma by Targeting VEGFA

The Long Non-Coding RNA SNHG1 Promotes Glioma Progression by Competitively Binding to Mir-194 to Regulate PHLDA1 Expression

Upregulation of the Long Non-Coding RNA SNHG1 Predicts Poor Prognosis, Promotes Cell Proliferation and Invasion, and Reduces Apoptosis in Glioma.

The Long Noncoding Rna Zfas1 Promotes The Progression Of Glioma By Regulating The Mir-150-5p/Plp2 Axis

PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway

Interaction of NF-κB and FOSL1 drives glioma stemness

PDGFA/PDGFRα-regulated GOLM1 Promotes Human Glioma Progression Through Activation of AKT

Functional Linc-Pou3f3 is Overexpressed and Contributes to Tumorigenesis in Glioma.

Abstract 5388: FOSL1 promotes glioma tumorigenesis and stemness through NF-κB and STAT3 pathways

Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial–mesenchymal transition in vitro and predicts poor prognosis in glioma

LncRNA-PVT1 Indicates a Poor Prognosis and Promotes Angiogenesis Via Activating the HNF1B/EMT Axis in Glioma

Retraction Note: MYC-mediated Upregulation of PNO1 Promotes Glioma Tumorigenesis by Activating THBS1/FAK/Akt Signaling

Long Noncoding RNA LINC00467 Promotes Glioma Progression Through Inhibiting P53 Expression Via Binding to DNMT1.

Overexpression of SHCBP1 Promotes Migration and Invasion in Gliomas by Activating the NF‐κB Signaling Pathway

Lncrna SNHG16 Promotes Glioma Tumorigenicity Through Mir-373/Egfr Axis by Activating PI3K/AKT Pathway.

FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis

Epigenetic and Transcriptional Activation of the Secretory Kinase FAM20C As an Oncogene in Glioma

LINC00174 is a Favorable Prognostic Biomarker in Glioblastoma Via Promoting Proliferative Phenotype.